Kleindienst et al., 2016 - Google Patents
Virus risk mitigation in cell culture mediaKleindienst et al., 2016
View HTML- Document ID
- 362754921506546315
- Author
- Kleindienst B
- Manzke A
- Publication year
- Publication venue
- BioPharm International
External Links
Snippet
The contamination of bioreactors with various infective agents such as bacteria, mycoplasma, and viruses is a potential risk to patient safety. Viruses have been the cause of multiple bioreactor contaminations in recent years (1). A number of biopharmaceutical …
- 241000700605 Viruses 0 title abstract description 46
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION, OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES
- A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
- A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
- A61L2/0011—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using physical methods
- A61L2/0017—Filtration
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Kleindienst et al. | Virus risk mitigation in cell culture media | |
| US11421202B2 (en) | Virus filtration of cell culture media | |
| Abushaban et al. | Assessing pretreatment effectiveness for particulate, organic and biological fouling in a full-Scale SWRO desalination plant | |
| Grote et al. | Downstream of downstream processing: development of recycling strategies for biopharmaceutical processes | |
| Angart et al. | Considerations for risk and control of mycoplasma in bioprocessing | |
| Wieser et al. | Protection of biomanufacturing processes from virus contamination through upstream virus filtration of cell culture media | |
| Carson et al. | Photoreactivation of Pseudomonas cepacia after ultraviolet exposure: a potential source of contamination in ultraviolet-treated waters | |
| Eissa | Bioburden control in the biopharmaceutical industry | |
| Hernandez | Selecting a Comprehensive Bioburden Reduction Plan | |
| Kanarek et al. | Sustainable Water Use in a Fruit Processing Plant: Evaluation of Microbiological and Physicochemical Properties of Wash Water after Application of a Modular Water Recovery System | |
| Sandle | Utilities Design and Testing | |
| Grant et al. | Investigation of the impact of simulated commercial centrifugation and microfiltration conditions on levels of Mycobacterium avium ssp. paratuberculosis in milk | |
| Gemmell | Viral Safety Challenges in Bioprocessing. | |
| Ahmad Wadi et al. | Effects of Strain Differences, Humidity Changes, and Saliva Contamination on the Inactivation of SARS-CoV-2 by Ion Irradiation | |
| Sarkar | Viral Clearance in the Manufacture of Biologics: Bioprocessors have had a good handle on viral safety, but they need to keep their grip as they shift toward continuous processing and boost production of gene and cell therapies | |
| Dunn | PureBright® New Sterilization Pulsed-Light Method Sterilization: A | |
| Vaghari et al. | Sterilization process | |
| Keyser et al. | The Application of Sterile Filtration Technology in the Environmental Control and Life Support Systems of Space Station Freedom | |
| Parrella et al. | RUNspike, a complementary virus filter spiking method: a solution to the problem of reduced throughput due to the addition of the virus spike | |
| Davis et al. | C Squared Consulting LLP | |
| Onadipe | 5A Microbiological | |
| Blake et al. | BPOG Response to Annex 2 | |
| World Health Organization | Production of water for injection by means other than distillation | |
| Pollet et al. | From gene to clinical product: an overview of GMP requirements associated to the development of new biotherapeutics, in a multiprocess/multiproduct facility | |
| Smith | Clearing Viral Concerns in Animal-Derived Biomaterials |